Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

作者：Mikhail Kosiborod, John Deanfield, Richard Pratley, Barry A. Borlaug, Javed Butler, Melanie J. Davies, Scott S. Emerson, Steven E. Kahn, Dalane W. Kitzman, Ildiko Lingvay, Kenneth W. Mahaffey, Mark C. Petrie, Jorge Plutzky, Søren Rasmussen, Cecilia Rönnbäck, Sanjiv J. Shah, Subodh Verma, Peter Weeke, A. Michael Lincoff · 发表于：The Lancet · 年份：2024 · DOI：10.1016/s0140-6736(24)01643-x · 被引用次数：304 · 研究领域：Diabetes Treatment and Management、Cardiovascular Function and Risk Factors、Heart Failure Treatment and Management